| Literature DB >> 31446144 |
Alyssa Ekdahl1, Deanna Mudie2, David Malewski3, Greg Amidon4, Aaron Goodwin5.
Abstract
Amorphous solid dispersions (ASDs) are commonly used to enhance the oral absorption of drugs with solubility or dissolution rate limitations. Although the ASD formulation is typically constrained by physical stability and in vivo performance considerations, ASD particles can be engineered using the spray-drying process to influence mechanical and flow properties critical to tableting. Using the ASD formulation of 20% w/w felodipine dispersed in polyvinyl pyrrolidone vinyl acetate, spray-drying atomization and drying conditions were tuned to achieve 4 different powders with varying particle properties. The resulting particles ranged in volume moment mean diameter from 4 to 115 μm, bulk density from 0.05 to 0.38 g cm-3, and morphologies of intact, collapsed, and fractured hollow spheres. Powder flowability by shear cell ranged from poor to easy flowing, whereas mechanical property tests suggested all samples will produce strong tablets at reasonable solid fractions and compression pressures. In addition, Hiestand dynamic tableting indices showed excellent dynamic bonding for 3 powders, and low viscoelasticity with high brittleness for all powders. This work demonstrates the extent spray-dried ASD particle morphologies can be engineered to achieve desired powder flow and mechanical properties to mitigate downstream processing risks and increase process throughput.Entities:
Keywords: amorphous solid dispersions; bioavailability; mechanical properties; oral drug delivery; particle size; poorly water-soluble drugs; solid dosage form; spray drying; tableting
Mesh:
Substances:
Year: 2019 PMID: 31446144 DOI: 10.1016/j.xphs.2019.08.008
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534